Xperiome

📍 London, United Kingdom👥 1 employees💰 Last funded Sep 2018
Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient’s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Xperiome?
Xperiome has 1 investors on record on gritt.io, 1 mid-stage.
When did Xperiome last raise funding?
The most recent investment in Xperiome recorded on gritt.io was in September 2018.
What industry is Xperiome in?
Xperiome operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is Xperiome based?
Xperiome is headquartered in London, United Kingdom.